Citations (52)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Louis M Pelus & Sherif S Farag. (2011) Increased mobilization and yield of stem cells using plerixafor in combination with granulocyte-colony stimulating factor for the treatment of non-Hodgkin’s lymphoma and multiple myeloma. Stem Cells and Cloning: Advances and Applications 4, pages 11-22.
Read now
Read now
Articles from other publishers (51)
Normann Steiner, Georg Göbel, Leonie Mauser, Lena Mühlnikel, Marie Fischinger, Tina Künz, Wolfgang Willenbacher, Gabriele Hetzenauer, Jakob Rudzki, Walter Nussbaumer, Wolfgang Mayer, Eberhard Gunsilius, Brigitte Kircher, Dominik Wolf & David Nachbaur. (2023) Poor Mobilizers in Lymphoma but Not Myeloma Patients Had Significantly Poorer Progression-Free Survival after Autologous Stem Cell Transplantation: Results of a Large Retrospective, Single-Center Observational Study. Cancers 15:3, pages 608.
Crossref
Crossref
Justin du Toit, Marco Goeijenbier, Cecile du Toit, Pieter de Witt, Hannes Koornhof, Jenna Oosthuizen, Vernon Johan Louw, Matthew Seftel & Estelle Verburgh. (2022) Predictors of poor haematopoietic stem cell mobilisation in patients with haematological malignancies at a South African centre. Transfusion and Apheresis Science 61:4, pages 103419.
Crossref
Crossref
Mesut Göçer & Erdal Kurtoğlu. (2020)
Is absence of
CD56
a predictive factor for peripheral blood stem cell mobilization failure in patients with multiple myeloma?
. Journal of Clinical Apheresis 36:3, pages 332-339.
Crossref
Crossref
Jun Zhu, Huiqiang Huang, Huan Chen, Xi Zhang, Zengjun Li, Depei Wu, Daobin Zhou, Yongping Song, Yu Hu, Yingmin Liang, Hanyun Ren, He Huang, Nainong Li, Hu Chen, Jiong Hu, Jianyong Li, Robin Meng, Junlong Wu, Dong Yu & Xiaojun Huang. (2018) Plerixafor and granulocyte-colony-stimulating factor for mobilization of hematopoietic stem cells for autologous transplantation in Chinese patients with non−Hodgkin's lymphoma: a randomized Phase 3 study. Transfusion 58:1, pages 81-87.
Crossref
Crossref
Shan YuanShirong Wang. (2016) How do we mobilize and collect autologous peripheral blood stem cells?. Transfusion 57:1, pages 13-23.
Crossref
Crossref
Fernando Barroso Duarte, Benedito de Pina Almeida Prado, Garles Miller Matias Vieira & Luciano J. Costa. (2016) Mobilization of hematopoietic progenitor cells for autologous transportation: consensus recommendations. Revista da Associação Médica Brasileira 62:suppl 1, pages 10-15.
Crossref
Crossref
Ivetta Danylesko, Rina Sareli, Nira Varda-Bloom, Ronit Yerushalmi, Noga Shem-Tov, Avichai Shimoni & Arnon Nagler. (2016) Plerixafor (Mozobil): A Stem Cell-Mobilizing Agent for Transplantation in Lymphoma Patients Predicted to Be Poor Mobilizers - A Pilot Study. Acta Haematologica 135:1, pages 29-36.
Crossref
Crossref
Russell Emmons, Grace M. Niemiro & Michael De Lisio. (2016) Exercise as an Adjuvant Therapy for Hematopoietic Stem Cell Mobilization. Stem Cells International 2016, pages 1-11.
Crossref
Crossref
S. Akhtar, T. A. M. Elhassan, W. Edesa, M. S. Rauf, M. N. Zahir & I. Maghfoor. (2015) High-dose chemotherapy and autologous stem cell transplantation for relapsed or refractory nodular lymphocyte predominant Hodgkin lymphoma. Annals of Hematology 95:1, pages 49-54.
Crossref
Crossref
Yuankai Shi, Ping Zhou, Xiaohong Han, Xiaohui He, Shengyu Zhou, Peng Liu, Jianliang Yang, Changgong Zhang, Lin Gui, Yan Qin, Sheng Yang, Liya Zhao, Jiarui Yao & Shuxiang Zhang. (2015) Autologous peripheral blood stem cell mobilization following dose-adjusted cyclophosphamide, doxorubicin, vincristine, and prednisolone chemotherapy alone or in combination with rituximab in treating high-risk non-Hodgkin’s lymphoma. Chinese Journal of Cancer 34:3.
Crossref
Crossref
Sinem Civriz Bozdag, Emre Tekgunduz & Fevzi Altuntas. (2015) The current status in hematopoietic stem cell mobilization. Journal of Clinical Apheresis 30:5, pages 273-280.
Crossref
Crossref
Emily Storch, Tomer Mark, Scott Avecilla, Carlos Pagan, Joanna Rhodes, Tsiporah Shore, Koen van Besien & Melissa Cushing. (2015) A novel hematopoietic progenitor cell mobilization and collection algorithm based on preemptive CD34 enumeration. Transfusion 55:8, pages 2010-2016.
Crossref
Crossref
Hakan Goker, Sezgin Etgul & Yahya Buyukasik. (2015) Optimizing mobilization strategies in difficult-to-mobilize patients: The role of plerixafor. Transfusion and Apheresis Science 53:1, pages 23-29.
Crossref
Crossref
Fatih Kurnaz & Leylagül Kaynar. (2015) Peripheral blood stem cell mobilization failure. Transfusion and Apheresis Science 53:1, pages 3-7.
Crossref
Crossref
Manuel Afable, Paolo F. Caimi, Chitra Hosing, Marcos de Lima, Issa Khouri, Basem M. William, Yago Nieto, Brenda W. Cooper, Paolo Anderlini, Stanton L. Gerson, Hillard M. Lazarus, Richard Champlin & Uday Popat. (2015) Hematopoietic Progenitor Cell Harvesting Is Feasible after Treatment with Brentuximab Vedotin in CD30+ Lymphoma Patients Who Received Multiple Prior Lines of Treatment. Biology of Blood and Marrow Transplantation 21:8, pages 1529-1531.
Crossref
Crossref
Miguel-Angel Perales, Izaskun Ceberio, Philippe Armand, Linda J. Burns, Robert Chen, Peter D. Cole, Andrew M. Evens, Ginna G. Laport, Craig H. Moskowitz, Uday Popat, Nishitha M. Reddy, Thomas C. Shea, Julie M. Vose, Jeffrey Schriber, Bipin N. Savani & Paul A. Carpenter. (2015) Role of Cytotoxic Therapy with Hematopoietic Cell Transplantation in the Treatment of Hodgkin Lymphoma: Guidelines from the American Society for Blood and Marrow Transplantation. Biology of Blood and Marrow Transplantation 21:6, pages 971-983.
Crossref
Crossref
Yavuz M. Bilgin, Otto Visser, Erik A.M. Beckers, Liane CJ te Boome, Cynthia Huisman, Paula F. Ypma, Alexandra J. Croockewit, Tanja Netelenbos, Ellen PA Kramer & Georgine E. de Greef. (2014)
Evaluation of
D
utch guideline for just‐in‐time addition of plerixafor to stem cell mobilization in patients who fail with granulocyte–colony‐stimulating factor
. Transfusion 55:5, pages 1021-1027.
Crossref
Crossref
Muhammad Shahzad Rauf, Irfan Maghfoor, Tusneem Ahmed M. Elhassan & Saad Akhtar. (2014) High-dose chemotherapy and auto-SCT for relapsed and refractory Hodgkin’s lymphoma patients refractory to first-line salvage chemotherapy but responsive to second-line salvage chemotherapy. Medical Oncology 32:1.
Crossref
Crossref
K. H. Lee, S. K. Jung, S. J. Kim, J. H. Jang, K. Kim, W. S. Kim, C. W. Jung, D. W. Kim & E. S. Kang. (2014) Incidence and risk factors of poor mobilization in adult autologous peripheral blood stem cell transplantation: a single-centre experience. Vox Sanguinis 107:4, pages 407-415.
Crossref
Crossref
Tamara Girbl, Verena Lunzer, Richard Greil, Konrad Namberger & Tanja Nicole Hartmann. (2014)
The
CXCR
4 and adhesion molecule expression of
CD
34+ hematopoietic cells mobilized by “on‐demand” addition of plerixafor to granulocyte–colony‐stimulating factor
. Transfusion 54:9, pages 2325-2335.
Crossref
Crossref
D Sheppard, C Bredeson, L Huebsch, D Allan & J Tay. (2014) A plerixafor-based strategy allows adequate hematopoietic stem cell collection in poor mobilizers: results from the Canadian Special Access Program. Bone Marrow Transplantation 49:6, pages 751-755.
Crossref
Crossref
Sibel Hacıoğlu, Ismail Sarı, Mehmet Hilmi Doğu & Ali Keskin. (2014) The effect of gradual increment in rhG-CSF dose on stem cell yields in patients with multiple myeloma mobilized with intermediate dose cyclophosphamide plus rhG-CSF. Transfusion and Apheresis Science 50:1, pages 71-74.
Crossref
Crossref
Jonathan Hoggatt, Tiffany A. Tate & Louis M. Pelus. 2014. Hematopoietic Stem Cell Protocols. Hematopoietic Stem Cell Protocols
43
64
.
Jonathan Hoggatt, Jennifer M. Speth & Louis M. Pelus. (2013) Concise Review: Sowing the Seeds of a Fruitful Harvest: Hematopoietic Stem Cell Mobilization. Stem Cells 31:12, pages 2599-2606.
Crossref
Crossref
Ivana N. Micallef, Patrick J. Stiff, Edward A. Stadtmauer, Brian J. Bolwell, Auayporn P. Nademanee, Richard T. Maziarz, Angela M. Partisano, Sachin Marulkar & John F. DiPersio. (2013)
Safety and efficacy of upfront plerixafor + G‐CSF versus placebo + G‐CSF for mobilization of CD34
+
hematopoietic progenitor cells in patients ≥60 and <60 years of age with non‐Hodgkin's lymphoma or multiple myeloma
. American Journal of Hematology 88:12, pages 1017-1023.
Crossref
Crossref
S Akhtar, A S Al-Sugair, M Abouzied, Y AlKadhi, M Dingle, M Abdelsalam, H Soudy, A Darwish, A Eltigani, T A M Elhassan, M Nabil-Ahmed & I Maghfoor. (2013) Pre-transplant FDG-PET-based survival model in relapsed and refractory Hodgkin’s lymphoma: outcome after high-dose chemotherapy and auto-SCT. Bone Marrow Transplantation 48:12, pages 1530-1536.
Crossref
Crossref
Itır Şirinoğlu Demiriz, Sinem Civriz Bozdağ, Emre Tekgündüz, Bilge Uğur, Gamze Durgun, Şerife Koçubaba & Fevzi Altuntaş. (2013) Predicting the successful peripheral blood stem cell harvesting. Transfusion and Apheresis Science 48:3, pages 411-414.
Crossref
Crossref
Yvette C. Tanhehco, Dan T. Vogl, Edward A. Stadtmauer & Una O'Doherty. (2013) The evolving role of plerixafor in hematopoietic progenitor cell mobilization. Transfusion, pages n/a-n/a.
Crossref
Crossref
Andreas Humpe, Ute Buwitt-Beckmann, Natalie Schub, Martin Gramatzki & Andreas Günther. (2013) Successful Mobilization, Intra-Apheresis Recruitment, and Harvest of Hematopoietic Progenitor Cells by Addition of Plerixafor and Subsequent Large-Volume Leukapheresis. Transfusion Medicine and Hemotherapy 40:4, pages 251-257.
Crossref
Crossref
Nicola Piccirillo, Michele Vacca, Alessandro Lanti, Francesco Ipsevich, Maddalena Maresca, Elena Fiorelli, Maria Bianchi, Gaspare Adorno, Luca Pierelli, Ignazio Majolino, Giuseppe Leone & Gina Zini. (2012) Poor mobilizer: A retrospective study on proven and predicted incidence according to GITMO criteria. Transfusion and Apheresis Science 47:2, pages 217-221.
Crossref
Crossref
M E Horwitz, J P Chute, C Gasparetto, G D Long, C McDonald, A Morris, D A Rizzieri, K M Sullivan & N J Chao. (2011) Preemptive dosing of plerixafor given to poor stem cell mobilizers on day 5 of G-CSF administration. Bone Marrow Transplantation 47:8, pages 1051-1055.
Crossref
Crossref
K Hübel, M M Fresen, J F Apperley, G W Basak, K W Douglas, I H Gabriel, C Geraldes, O Jaksic, Z Koristek, N Kröger, F Lanza, R M Lemoli, G Mikala, D Selleslag, N Worel, M Mohty & R F Duarte. (2011) European data on stem cell mobilization with plerixafor in non-Hodgkin's lymphoma, Hodgkin's lymphoma and multiple myeloma patients. A subgroup analysis of the European Consortium of stem cell mobilization. Bone Marrow Transplantation 47:8, pages 1046-1050.
Crossref
Crossref
Dawn Sheppard, Christopher Bredeson, David Allan & Jason Tay. (2012) Systematic Review of Randomized Controlled Trials of Hematopoietic Stem Cell Mobilization Strategies for Autologous Transplantation for Hematologic Malignancies. Biology of Blood and Marrow Transplantation 18:8, pages 1191-1203.
Crossref
Crossref
Prakash Vishnu, Vivek Roy, Athena Paulsen & Abba C. Zubair. (2012) Efficacy and cost-benefit analysis of risk-adaptive use of plerixafor for autologous hematopoietic progenitor cell mobilization. Transfusion 52:1, pages 55-62.
Crossref
Crossref
Maximilian M. Fresen & Kai Hübel. 2012. Novel Developments in Stem Cell Mobilization. Novel Developments in Stem Cell Mobilization
221
234
.
Xiaohong Han, Li Ma, Lingdi Zhao, Xiaohui He, Peng Liu, Shengyu Zhou, Jianliang Yang, Yan Qin, Sheng Yang, Jiarui Yao & Yuankai Shi. (2012) Predictive factors for inadequate stem cell mobilization in Chinese patients with NHL and HL: 14‐year experience of a single‐center study. Journal of Clinical Apheresis 27:2, pages 64-74.
Crossref
Crossref
Guner Hayri Ozsan, Ivana N. Micallef, Angela Dispenzieri, Shaji Kumar, Martha Q. Lacy, David Dingli, Suzanne R. Hayman, Francis K. Buadi, Robert C. Wolf, Dennis A. Gastineau, William J. Hogan & Morie A. Gertz. (2011) Hematopoietic recovery kinetics predicts for poor CD34+ cell mobilization after cyclophosphamide chemotherapy in multiple myeloma. American Journal of Hematology 87:1, pages 1-4.
Crossref
Crossref
Jie Li, Ellie Hamilton, Louette Vaughn, Michael Graiser, Heather Renfroe, Mary Jo Lechowicz, Amelia Langston, Jefferson Mark Prichard, Darlene Anderson, Charise Gleason, Sagar Lonial, Christopher R. Flowers, Jonathan L. Kaufman & Edmund K. Waller. (2011) Effectiveness and cost analysis of “just-in-time” salvage plerixafor administration in autologous transplant patients with poor stem cell mobilization kinetics. Transfusion 51:10, pages 2175-2182.
Crossref
Crossref
L. Bik To, Jean-Pierre Levesque, Kirsten E. Herbert, Ingrid G. Winkler, Linda J. Bendall, Devendra K. Hiwase, Vicki Antonenas, Alison M. Rice, David Gottlieb, Anthony K. Mills, John E.J. Rasko, Stephen Larsen, Ashanka Beligaswatte, Susan K. Nilsson, Julian P. Cooney, Antony C. Cambareri & Ian D. Lewis. (2011) Mobilisation strategies for normal and malignant cells. Pathology 43:6, pages 547-565.
Crossref
Crossref
K Hübel, M M Fresen, H Salwender, N Basara, R Beier, S Theurich, M Christopeit, C Bogner, O Galm, R Hartwig, F Heits, F Lordick, W Rösler, D Wehler, A R Zander, M H Albert, S Dressler, M Ebinger, N Frickhofen, B Hertenstein, M Kiehl, S Liebler, M von Lilienfeld-Toal, E Weidmann, C Weigelt, F Lange & N Kröger. (2010) Plerixafor with and without chemotherapy in poor mobilizers: results from the German compassionate use program. Bone Marrow Transplantation 46:8, pages 1045-1052.
Crossref
Crossref
Patrick J. Stiff, Ivana Micallef, Auayporn P. Nademanee, Edward A. Stadtmauer, Richard T. Maziarz, Brian J. Bolwell, Gary Bridger, Sachin Marulkar, Frank J. Hsu & John F. DiPersio. (2011) Transplanted CD34+ Cell Dose Is Associated with Long-Term Platelet Count Recovery following Autologous Peripheral Blood Stem Cell Transplant in Patients with Non-Hodgkin Lymphoma or Multiple Myeloma. Biology of Blood and Marrow Transplantation 17:8, pages 1146-1153.
Crossref
Crossref
Mohamad Mohty & Anthony D. Ho. (2011) In and out of the niche: perspectives in mobilization of hematopoietic stem cells. Experimental Hematology 39:7, pages 723-729.
Crossref
Crossref
M Mohty, R F Duarte, S Croockewit, K Hübel, G Kvalheim & N Russell. (2011) The role of plerixafor in optimizing peripheral blood stem cell mobilization for autologous stem cell transplantation. Leukemia 25:1, pages 1-6.
Crossref
Crossref
M A Gertz, R C Wolf, I N M Micallef & D A Gastineau. (2010) Clinical impact and resource utilization after stem cell mobilization failure in patients with multiple myeloma and lymphoma. Bone Marrow Transplantation 45:9, pages 1396-1403.
Crossref
Crossref
Patrick Wuchter, Dan Ran, Thomas Bruckner, Thomas Schmitt, Mathias Witzens-Harig, Kai Neben, Hartmut Goldschmidt & Anthony D. Ho. (2010) Poor Mobilization of Hematopoietic Stem Cells—Definitions, Incidence, Risk Factors, and Impact on Outcome of Autologous Transplantation. Biology of Blood and Marrow Transplantation 16:4, pages 490-499.
Crossref
Crossref
Zübeyde Nur Özkurt, Zeynep Arzu Yeǧin, Elif Suyanı, Şahika Zeynep Akı, Kadir Acar, Münci Yaǧcı & Gülsan Türköz Sucak. (2010) Factors affecting stem cell mobilization for autologous hematopoietic stem cell transplantation. Journal of Clinical Apheresis 25:5, pages 280-286.
Crossref
Crossref
Yvette C. Tanhehco, Jill Adamski, Mary Sell, Kathleen Cunningham, Christa Eisenmann, Deborah Magee, Edward A. Stadtmauer & Una O'Doherty. (2010) Plerixafor mobilization leads to a lower ratio of CD34+ cells to total nucleated cells which results in greater storage costs. Journal of Clinical Apheresis 25:4, pages 202-208.
Crossref
Crossref
John F. DiPersioIvana N. MicallefPatrick J. StiffBrian J. BolwellRichard T. MaziarzEric JacobsenAuayporn NademaneeJohn McCartyGary BridgerGary Calandra. (2009) Phase III Prospective Randomized Double-Blind Placebo-Controlled Trial of Plerixafor Plus Granulocyte Colony-Stimulating Factor Compared With Placebo Plus Granulocyte Colony-Stimulating Factor for Autologous Stem-Cell Mobilization and Transplantation for Patients With Non-Hodgkin's Lymphoma. Journal of Clinical Oncology 27:28, pages 4767-4773.
Crossref
Crossref
Chitra Hosing, Rima M. Saliba, Sheena Ahlawat, Martin Körbling, Partow Kebriaei, Amin Alousi, Marcos De Lima, Julia‐Grace Okoroji, John McMannis, Muzaffar Qazilbash, Paolo Anderlini, Sergio Giralt, Richard E. Champlin, Issa Khouri & Uday Popat. (2009) Poor hematopoietic stem cell mobilizers: A single institution study of incidence and risk factors in patients with recurrent or relapsed lymphoma. American Journal of Hematology 84:6, pages 335-337.
Crossref
Crossref
Douglas A. Stewart, Clayton Smith, Ron MacFarland & Gary Calandra. (2009) Pharmacokinetics and Pharmacodynamics of Plerixafor in Patients with Non-Hodgkin Lymphoma and Multiple Myeloma. Biology of Blood and Marrow Transplantation 15:1, pages 39-46.
Crossref
Crossref
. (2008) Current Awareness in Hematological Oncology. Hematological Oncology 26:4, pages 253-260.
Crossref
Crossref